AngioDynamics (ANGO) Misses Q1 EPS by 4c, Reaffirms FY18 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St mixed as benchmark Treasury yields reach 5%, oil takes a pause
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
AngioDynamics Reports Fiscal 2018 First Quarter Results
September 28, 2017 6:00 AM EDTQ1 net sales of $85.4 million, down 3% year-over-year       Q1 GAAP earnings per share of $0.00; adjusted EPS of $0.12Q1 operating cash generation of $3.0 million; free cash flow generation of $2.5 millionCompany reaffirms fiscal 2018 guidance
ALBANY, N.Y., Sept. 28, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported first quarter financial results for the 2018 fiscal year ended August 31, 2017.
The first quarter of fiscal 2018 reflects early results of our commitment to improving our core operational efficiency and... More
